Primary hepatic carcinoid tumorTakayuki Asakawa, Takashi Kanematsu, Takashi Yamaguchi et al.|Journal of Gastroenterology|1999Cited by 37
10P Phase I study of magrolimab (ONO-7913) and nivolumab (ONO-4538, NIV) in combination with FOLFOX and bevacizumab (Bev) or cetuximab (Cet) as first-line treatment in patients with unresectable advanced or recurrent colorectal cancer (CRC)K. Yamaguchi, T. Yoshino, A. Takashima et al.|Annals of Oncology|2025Cited by 2
[Acupuncture treatment for a patient with diffuse axonal injury--report no. 2].Hideaki Tamai, Norimasa Seo, Senichiro Kikuchi et al.|PubMed|2007Cited by 0